We are live on ! Find out more
ONTXW

Onconova Therapeutics, Inc. Warrants
ONTXW

Delisted

ONTXW was delisted on the 23rd of July, 2021.

Back to rankings

5 hedge funds and large institutions have $26K invested in Onconova Therapeutics, Inc. Warrants in 2019 Q3 according to their latest regulatory filings, with funds opening new positions, 1 increasing their positions, 1 reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 5 → 5 (0)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

0% more repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 1

88% less capital invested

Capital invested by funds: $226K → $26K (-$200K)

Holders
5
Holders Change
–
Holders Change %
0%
% of All Funds
0.11%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
–
Increased
1
Reduced
1
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$32

Top Sellers

Rank Fund Capital Flow
1
SM
Sabby Management
Florida
-$736

ONTXW Hedge Fund Activity: Q3 2019 in Review

5 of the 4,574 institutional investors tracked by Wall St. Rank reported a position in Onconova Therapeutics, Inc. Warrants (ONTXW) for Q3 2019, worth a combined $26K — down 88% from $226K a quarter earlier.

Fund positioning in ONTXW was balanced in Q3 2019: 0 funds opened new positions, 0 closed out, 1 added to existing stakes and 1 trimmed.

The largest buyer was Susquehanna International Group, adding an estimated $32. The largest seller was Sabby Management, cutting an estimated $736.

  • 5 institutional investors held Onconova Therapeutics, Inc. Warrants (ONTXW) as of Q3 2019, unchanged from Q2 2019.
  • Funds reported $26K of Onconova Therapeutics, Inc. Warrants stock for Q3 2019, down 88% quarter-over-quarter.
  • 0 funds opened new Onconova Therapeutics, Inc. Warrants positions in Q3 2019 and 0 closed out.
  • The largest Onconova Therapeutics, Inc. Warrants buyer in Q3 2019 was Susquehanna International Group, an estimated $32 added.
  • The largest Onconova Therapeutics, Inc. Warrants seller in Q3 2019 was Sabby Management, an estimated $736 sold.

Based on aggregated 13F filings for Q3 2019.